| Afrigen Biologics and Vaccines: International Licensing or Acquisition? |
| 作者姓名：Abiodun E. Awosusi, Paul W. Beamish, Vanessa C. Hasse, Ning Su |
| 商品類型：Case (Field) | 商品編號：W41360 |
| 出版日期：2024/11/26 | 內容長度：14 頁 |
Afrigen Biologics (Pty) Ltd. (Afrigen) was a biotech firm with a track record of solid performance in the sector with its leadership in sharing mRNA technology and developing a vaccine for COVID-19. By August 2024, with the threat of the COVID-19 pandemic under control, the firm was ready to capitalize on its track record and pivot. Petro Terblanche, CEO of Afrigen, needed to decide, therefore, what the firm’s next steps would be. What should the .....more
|
| Afrigen Biologics and Vaccines: International Licensing or Acquisition? - Teaching Note |
| 作者姓名：Abiodun E. Awosusi, Paul W. Beamish, Vanessa C. Hasse, Ning Su |
| | 商品編號：W41361 |
| 出版日期：2024/11/26 | 內容長度：13 頁 |
Teaching note for product W41360.
|